Spero Therapeutics, Inc. ($SPRO)
Filing Information
| Accession Number | 0001193125-26-283209 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 25, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
30,000
Total Value
$0.00
P&L
+inf% (+$60,600.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jun 23, 2026 | Grant/Award | 10,000 | $0.00 | $0.00 | 85,000 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Jun 23, 2026 | Grant/Award | 20,000 | $0.00 | $0.00 | 20,000 | Direct | โ | View Details |